| | Identification | Back Directory |  | [Name] 
 PICROSIDE I
 |  | [CAS] 
 27409-30-9
 |  | [Synonyms] 
 PICROSIDE I
 Picroside-Ⅰ
 AMphicoside I
 Amphicoside Ⅰ
 PICOLINIC ACID(P)
 Other Cas No, 76248-14-1
 β-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-
 Picroside I, 98%, from Picrorhiza scrophulariiflora Pennel
 6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl,6-(3-phenyl-2-propenoate), [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα]]-
 (1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-β-D-glucopyranoside 6-[(2E)-3-phenyl-2-propenoate]
 β-D-Glucopyranoside, (1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-[(2E)-3-phenyl-2-propenoate]
 (1aS,1bS,2S,5aR,6S,6aS)-6-Hydroxy-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl 6-O-[(2E)-3-phenyl-2-propenoyl]-beta-D-glucopyranoside
 β-d-Glucopyranoside,  1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl,  6-(3-phenyl-2-propenoate),  [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα]]-
 [1aS-[1aalpha,1bbeta,2beta(E),5abeta,6beta,6aalpha]]-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl 6-(3-phenyl-2-propenoate) beta-D-glucopyranoside
 beta-d-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-(3-phenyl-2-propenoate), [1aS-[1aalpha,1bbeta,2beta(E),5abeta,6beta,6aalpha]]-
 |  | [EINECS(EC#)] 
 248-445-1
 |  | [Molecular Formula] 
 C24H28O11
 |  | [MDL Number] 
 MFCD00017720
 |  | [MOL File] 
 27409-30-9.mol
 |  | [Molecular Weight] 
 492.47
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 778.6±60.0 °C(Predicted)
 |  | [density ] 
 1.56±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 2-8°C
 |  | [solubility ] 
 ethanol: soluble1mg/mL, clear, colorless
 |  | [form ] 
 powder
 |  | [pka] 
 12.70±0.70(Predicted)
 |  | [color ] 
 White
 |  | [InChIKey] 
 BSYHSWKTXMTFNF-NTLZGZQOSA-N
 |  | [SMILES] 
 [C@]12(CO)O[C@H]1[C@H]([C@]1([H])C=CO[C@@H](O[C@H]3[C@H](O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@]21[H])OC(=O)/C=C/C1=CC=CC=C1 |&1:0,4,5,6,11,13,14,16,17,19,24,r|
 | 
 | Hazard Information | Back Directory |  | [Description] 
 Picroliv is a hepatoprotective mixture of compounds that is isolated from an herb native to the Himalayas.1 Picroside I is an iridoid glycoside found in picroliv.1 By itself, picroside I blocks changes in acid phosphatase activity, phospholipid levels, and lipid peroxide production induced by D-galactosamine in rat liver.2 Picroside I also enhances neurite outgrowth in PC12D cells induced by basic fibroblast growth factor and 7S nerve growth factor when given at 60 μM.3,4 At concentrations as low as 5 μM, picroside I enhances the ATPase activity of the efflux transporter P-glycoprotein.5
 |  | [Chemical Properties] 
 Yellow needle-shaped crystals, soluble in methanol, derived from Picrorhizoma Coptidis.
 |  | [Uses] 
 Picroside I acts as an oxygen free radical scavenger and thus promotes anti-inflammatory activity and may be used in the treatment of arthritis.
 |  | [in vivo] 
 
 Picroside I (20 mg/kg, o.p, 12 d) reduces AHR in the experimental asthma model and reduces OVA-associated IgE levels[2].
 | Animal Model: | Ovalbumin (OVA) systematic sensitization BALB/c mice model[2] |  | Dosage: | 0.2, 2.0 and 20 mg/kg |  | Administration: | Orally, once daily, from day 20 to day 32 |  | Result: | Inhibited allergen-triggered inflammatory cell infiltration. | 
 |  | [IC 50] 
 STAT6
 |  | [References] 
 [1] C. GIRISH   Suresh C P. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin[J]. Fundamental & Clinical Pharmacology, 2008, 22 6: 623-632. DOI: 10.1111/j.1472-8206.2008.00618.x
 [2] YOGESH DWIVEDI. Picroliv and its Components Kutkoside and Picroside I Protect Liver Against Galactosamine-Induced Damage in Rats[J]. Basic & Clinical Pharmacology & Toxicology, 1992, 71 5: 383-387. DOI: 10.1111/j.1600-0773.1992.tb00566.x
 [3] PING LI . Potentiation of nerve growth factor-action by picrosides I and II, natural iridoids, in PC12D cells[J]. European journal of pharmacology, 2000, 406 2: Pages 203-208. DOI: 10.1016/s0014-2999(00)00662-2
 [4] PING LI. Picrosides I and II, selective enhancers of the mitogen-activated protein kinase-dependent signaling pathway in the action of neuritogenic substances on PC12D cells[J]. Life sciences, 2002, 71 15: Pages 1821-1835. DOI: 10.1016/s0024-3205(02)01949-5
 [5] I A NAJAR. Modulation of P-glycoprotein ATPase activity by some phytoconstituents.[J]. Phytotherapy Research, 2010: 454-458. DOI: 10.1002/ptr.2951
 | 
 |  |